Placebo matching Saxagliptin
Sponsors
AstraZeneca
Conditions
Diabetes Mellitus, Type 2Type 2 Diabetes
Phase 3
Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
CompletedNCT00121641
Start: 2005-07-31End: 2010-02-28Updated: 2015-04-03
Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg
CompletedNCT00918138
Start: 2009-08-31End: 2010-05-31Updated: 2015-05-21